Credit Suisse’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
2021
Q2
$107K Buy
2020
Q4
Sell
2020
Q3
$49K Buy
2017
Q4
Sell
2017
Q3
$96K Buy
2016
Q3
Sell
2016
Q2
$111K Buy